Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Maxwell Roger Lloyd, M.D.

Concepts (75)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hyperammonemia12020710.680 Why?
Protein-Energy Malnutrition120201880.660 Why?
Bariatric Surgery120209560.360 Why?
Obesity, Morbid1202012170.330 Why?
Breast Neoplasms72023207230.270 Why?
Cyclin-Dependent Kinase 4220235350.210 Why?
Legionella12021300.200 Why?
Lung Abscess12021420.200 Why?
Empyema, Pleural12021620.190 Why?
Cyclin-Dependent Kinase 6120223200.170 Why?
Breast Neoplasms, Male120202090.160 Why?
Pleural Effusion120213400.160 Why?
Protein Kinase Inhibitors3202355060.140 Why?
Comprehensive Health Care120161260.130 Why?
Leukemia, Myeloid, Acute2202134870.130 Why?
Enteral Nutrition120207690.120 Why?
DNA, Neoplasm1201717580.100 Why?
Receptor, erbB-21202224140.100 Why?
Myelodysplastic Syndromes1202113450.100 Why?
Genomics3202257070.100 Why?
Pneumonia1202121390.080 Why?
Artificial Intelligence1202221920.080 Why?
Cell Cycle Proteins1202034560.080 Why?
Neoplasm Metastasis1201748400.070 Why?
Drug Resistance, Neoplasm1202051500.060 Why?
Neoplasm Recurrence, Local1202092360.050 Why?
Chest Tubes120211490.050 Why?
Retinoblastoma Binding Proteins12020950.040 Why?
Receptors, Steroid120201550.040 Why?
Genes, p53120217580.040 Why?
Stem Cell Niche120213480.040 Why?
Humans1120237435210.040 Why?
Antineoplastic Agents12020136470.040 Why?
Female820233798750.040 Why?
Drainage1202111420.030 Why?
Neoplasm Staging22020110180.030 Why?
Gene Dosage1201712520.030 Why?
Proto-Oncogene Proteins p21(ras)1202016890.030 Why?
Receptors, Progesterone1201610990.030 Why?
Proto-Oncogene Proteins c-akt1202024920.020 Why?
Bone Marrow1202129460.020 Why?
Tumor Suppressor Protein p531202129420.020 Why?
Prognosis22022290000.020 Why?
Ubiquitin-Protein Ligases1202018540.020 Why?
Postoperative Care1201614870.020 Why?
Kaplan-Meier Estimate1202065350.020 Why?
Antigens, Neoplasm1201719940.020 Why?
Tumor Microenvironment1202135660.020 Why?
Hematopoietic Stem Cells1202133870.020 Why?
DNA Mutational Analysis1201741760.020 Why?
Receptors, Estrogen1201621720.020 Why?
Mastectomy1201617940.020 Why?
Chemotherapy, Adjuvant1201634750.020 Why?
Biopsy1202067300.020 Why?
Mammaplasty1201612020.020 Why?
Mutation22021297010.020 Why?
Disease Progression12023132490.020 Why?
Retrospective Studies22023774570.010 Why?
Reproducibility of Results12022198470.010 Why?
Cell Line, Tumor12020166180.010 Why?
Software1201744230.010 Why?
Adult320212138700.010 Why?
Practice Guidelines as Topic1201672710.010 Why?
Aged220201631370.010 Why?
Aged, 80 and over12020577390.010 Why?
Treatment Outcome12022631050.010 Why?
Middle Aged220202131850.010 Why?
Prostatic Neoplasms12017111200.010 Why?
Mice12021809990.010 Why?
Young Adult12020564100.010 Why?
Cohort Studies12016405450.010 Why?
Prospective Studies12017532850.010 Why?
Adolescent12020857570.010 Why?
Male220203497710.010 Why?
Animals120211684340.010 Why?
Lloyd's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (75)
Explore
_
Co-Authors (52)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.